Skip to main content
. Author manuscript; available in PMC: 2023 Sep 14.
Published in final edited form as: HIV Med. 2021 Sep 28;23(2):134–145. doi: 10.1111/hiv.13179

Table 1:

Age-standardised incidence of major cancers in people living with HIV in Australia between 1982 – 2012 (per 100,000 person-years) in three age groups, and overall.

Cancer1 Age Group 1982-1995 1996-1999 2000-2004 2005-2008 2009-2012 p-value*
AID defining cancers

Kaposi sarcoma Overall 996.70 305.20 123.85 63.04 64.79 <0.001
15-34 791.77 295.36 98.84 36.59 48.73 <0.001
35-64 1220.95 323.92 109.62 86.93 71.16 <0.001
65- 144.70 0.00 35.54 0.00 19.87 0.995

Non-Hodgkin lymphoma Overall 658.62 343.04 121.68 112.89 71.08 <0.001
15-34 292.37 346.37 73.87 117.16 45.89 0.027
35-64 770.93 362.86 152.35 101.65 91.62 <0.001
65- 901.74 133.84 52.38 101.92 82.29 0.001

Infection related non-AID defining cancers

Anal cancer Overall 26.82 18.76 25.40 38.41 44.97 0.002
15-34 4.41 12.40 0.00 4.55 4.34 0.621
35-64 24.49 16.99 41.13 41.69 66.44 <0.001
65- 84.83 0.00 34.86 105.22 71.43 0.553

Hodgkin lymphoma Overall 13.63 26.58 16.14 29.23 23.39 0.314
15-34 10.48 18.20 5.90 9.11 4.35 0.222
35-64 14.19 20.40 17.70 32.04 37.25 <0.001
65- 0.00 45.27 34.62 41.38 24.14 0.550

Liver cancer Overall 2.00 4.04 9.06 8.96 14.79 <0.001
15-34 0.00 0.00 0.00 0.00 0.00 N/A
35-64 4.13 8.35 13.32 18.53 26.65 <0.001
65- 0.00 0.00 16.57 0.00 12.03 0.470

Head and neck cancer Overall 10.67 2.87 9.61 5.77 7.64 0.765
15-34 0.00 2.99 0.00 0.00 0.00 N/A
35-64 22.05 3.72 14.43 11.93 15.79 0.839
65- 0.00 0.00 16.67 0.00 0.00 N/A

Non-infection related non-AID defining cancers

Lip cancer Overall 12.10 18.23 7.10 3.86 7.56 0.147
15-34 1.88 0.00 0.00 4.55 0.00 0.917
35-64 22.07 22.86 14.68 4.60 9.58 0.006
65- 0.00 45.42 0.00 0.00 18.55 0.912

Lung cancer Overall 13.85 26.48 27.47 16.72 31.17 0.300
15-34 4.41 0.00 0.00 0.00 0.00 N/A
35-64 9.88 39.82 29.04 27.09 39.96 0.227
65- 47.42 45.71 85.02 22.89 75.01 0.716

Colorectal cancer Overall 11.51 8.98 5.99 7.73 22.63 0.238
15-34 0.00 0.00 0.00 0.00 7.47 N/A
35-64 8.27 3.72 12.38 12.22 19.97 0.003
65- 47.58 45.49 0.00 11.50 44.59 0525

Stomach cancer Overall 7.44 0.00 7.47 8.34 5.81 0.665
15-34 0.00 0.00 0.00 0.00 0.00 N/A
35-64 0.00 0.00 10.03 0.00 9.91 0.382
65- 47.10 0.00 16.58 52.81 6.45 0.736

Melanoma Overall 39.61 31.98 28.02 30.67 33.00 0.249
15-34 14.59 15.40 23.43 0.00 4.35 0.291
35-64 57.25 42.09 21.48 32.09 37.33 0.142
65- 47.42 0.00 16.72 95.97 84.77 0.132

Prostate cancer Overall 49.72 35.47 24.28 66.39 39.44 0.853
15-34 0.00 0.00 0.00 0.00 0.00 N/A
35-64 59.00 16.43 5.48 44.66 50.17 0.869
65- 134.18 174.35 137.00 283.65 96.13 0.906
*

Linear regression model p value for trend

1

ICD10/O-3 codes: Kaposi sarcoma 9140, 8000 if KS on AIDS Registry, non-Hodgkin lymphoma 9591 9596, 9670-9729, 9820-9837, 9940, 9948 and 9590 if ICD10 C82-C85; Diffuse large B cell lymphoma 9680, 9684, 9678, 9679; Burkitt 9687, 9826; CNS lymphoma, non-Hodgkin lymphoma with C70-C72 topography; Hodgkin lymphoma 9650-9667; anus C21; Head and Neck cancer C01-C10, excluding C07-C08; liver C22; lip C00; melanoma c43; trachea, bronchus and lung C33-C34; colorectal C18-C20; prostate C61